| Long name: |
CD21/EBV receptor Primary Polyclonal Antibody |
| Also known as: |
CD21/EBV receptor PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
CD21/EBV receptor |
| Specificity: |
This is a highly specific antibody against CD21/EBV receptor |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen range: |
1050-1092/1092 |
| Subcellular location: |
Cell membrane, Cytoplasm |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CD21 |
| Gene ID number: |
1380 |
| Swiss Prot: |
P20023 |
| Tested Applications: |
FCM, IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
FCM(1:20-100), IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Participates in B lymphocytes activation, for the Epstein-Barr virus on human B-cells and T-cells and for HNRPU, Receptor for complement C3Dd |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
C3DR, CD21, CVID7, Complement C3d receptor, Complement receptor type 2, Cr2, EBV receptor, Epstein-Barr virus receptor, SLEB9, CR |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Description: |
2 or 3 and , However, In this sense, When such chemical-signals couple or bind to a receptor, a change in the electrical-activity of a cell, acetylcholine, am olfactory receptor is a protein-molecule that recognizes and responds to , an acetylcholine-receptor recognizes and responds to its endogenous-ligand, chemokinesor cytokines e, e, sometimes in pharmacology, such as enzymes, the term is also used to include other proteins that are drug-targets, they cause some form of cellular/tissue-response, transporters and ion-channels, The receptors are ligand binding factors of type 1, endogenous-chemical signals, g, g, protein-molecules , that receive chemical-signals from outside a cell |
| Gene target: |
CD21/EBV receptor |
| Short name: |
CD21/EBV receptor Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
CD21/EBV receptor (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
2336 |
| Gene: |
CR2 |
More about : CR2 |
| Long gene name: |
complement C3d receptor 2 |
| Synonyms gene name: |
complement component (3d/Epstein Barr virus) receptor 2 complement component 3d receptor 2 |
| Synonyms: |
CD21 C3DR |
| Synonyms name: |
Epstein-Barr virus receptor |
| Locus: |
1q32, 2 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
M26004 |
| Entrez gene record: |
1380 |
| RefSeq identity: |
NM_001877 |
| Classification: |
Sushi domain containing Complement system CD molecules |
| Havana BLAST/BLAT: |
OTTHUMG00000036307 |
| Locus Specific Databases: |
LRG_348 |